ILYANG PHARMACEUTICAL CO LTD

Stock Alert: Ilyang Pharma dives 9.8% in a volatile market, facing regulatory pressure and dilution from diversification—investor caution urged.

Ilyang Pharmaceutical’s share price slump reveals deep strategic drift and weak market cap, warning investors of rising risks and uncertain upside.

Ilyang Pharmaceutical’s share rose 0.14 % to KRW 7,060, trading near its 52‑week low while holding a solid market cap—steady gains amid a cautiously bullish Korean pharma sector.